About Daffodills Pharmaceuticals Limited
Data last updated:
Daffodills Pharmaceuticals Limited is a public limited company based in Meerut, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 May 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24233UP1985PLC007205. Its GSTIN is 09AAACD5022G1Z1 (Uttar Pradesh). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹5.5 Cr and a paid-up capital of ₹3.23 Cr. It was formerly known as Daffodills Pharmaceutical Private Limited. It is led by directors including Prabhat Kumar Rai (Whole-Time Director) and Kunwar Krishanpal Singh (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 770/1 Soti Ganj Behind Gurudwara, Meerut, Uttar Pradesh, India – 250001.
As per the financials filed for FY 2023, the company reported a revenue of ₹30.18 Cr, a growth of 32% compared to the previous year. For the same year it recorded a net profit of ₹52.19 Lakh (net margin 1.7%) and EBITDA of ₹80.28 Lakh (EBITDA margin 2.7%). Revenue has declined at a compounded annual rate (CAGR) of 8% over three years and 1% over five years.
The company has about 11 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Daffodills. As per MCA filings, the company has open charges of ₹16.93 Cr on record. Court records list 20 cases involving the company, including 15 filed by the company and 5 filed against it; 6 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website daffodills.in.
CIN History of Daffodills Pharmaceuticals Limited
Daffodills Pharmaceuticals has one previous CIN (Corporate Identification Number): L24233UP1985PLC007205. The current CIN is U24233UP1985PLC007205, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233UP1985PLC007205 | Current |
| L24233UP1985PLC007205 | Previous |
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address770/1 Soti Ganj Behind Gurudwara, Meerut, Uttar Pradesh, India – 250001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Daffodills Pharmaceuticals Limited
Daffodills Pharmaceuticals operates one associated brand: Daffodills. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and exports high-quality pharmaceutical formulations for domestic and international markets. | daffodills.in |
Financials of Daffodills Pharmaceuticals Limited FY 2025 filings available
Daffodills Pharmaceuticals Limited reported revenue of ₹30.18 Cr (up 32% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Daffodills Pharmaceuticals Limited
Revenue rose 32% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA fell 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Daffodills Pharmaceuticals Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹30.18 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹80.28 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹52.19 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Daffodills Pharmaceuticals Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Daffodills Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Daffodills Pharmaceuticals Limited
Daffodills Pharmaceuticals has 5 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pranav Chaudhary | Director | 22 Feb 2012 | 14 Years 7 Months | Current |
| Prateek Chaudhary Also directs: Ell Pee Medicare Private Limited | Director | 22 Feb 2012 | 14 Years 7 Months | Current |
| Prabhat Kumar Rai | Whole-Time Director | 30 Jul 2019 | 7 Years 2 Months | Current |
| Kunwar Krishanpal Singh | Whole-Time Director | 30 Jul 2019 | 7 Years 2 Months | Current |
| Prashant Chaudhry | Director | 02 Aug 2018 | 8 Years 2 Months | Current |
Auditor Details of Daffodills Pharmaceuticals Limited
Daffodills Pharmaceuticals Limited is audited by MEHRA AND COMPANY for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MEHRA AND COMPANY | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Daffodills Pharmaceuticals Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Daffodills Pharmaceuticals Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Oct 2025 | State Bank of India | ₹6.95 Cr | Open |
| 26 May 2025 | Axis Bank Limited | ₹4.6 Cr | Open |
| 20 Sep 2018 | Axis Bank Limited | ₹5 Cr | Open |
| 14 Oct 1995 | U. P. Financial Corporation | ₹38 Lakh | Open |
Total charge records: 4 View all charges
Legal Cases of Daffodills Pharmaceuticals Limited
Daffodills Pharmaceuticals Limited has 20 court cases on record: 15 filed by Daffodills Pharmaceuticals, 5 filed against it. 6 cases are pending and 14 are disposed. Status as checked between 28 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 17 | 2 | 4 |
| District courts | 3 | 3 | 2 |
Cases on record (5 of 20)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court for State of Telangana | Writ petition | Filed by the company against Aptonline Limited | Disposed |
| District court, Ghaziabad, Uttar Pradesh | Criminal case | Filed against the company by Union of India | Pending |
| Allahabad High Court | Court case (IAPL) | Filed against the company by Principle Commissioner of Income Tax | Pending |
| Allahabad High Court | Court case (CLRE) | Filed against the company by Municipal Cor. of Greater Mumbai | Pending |
| Allahabad High Court | Writ petition | Filed by the company against State of U.P | Pending |
Full case history
All 20 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Daffodills Pharmaceuticals Limited
Daffodills Pharmaceuticals Limited has a workforce of 11 employees as of Apr 01, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Daffodills Pharmaceuticals Limited
Daffodills Pharmaceuticals Limited has 8 board changes on record since 2012: 5 appointments and 3 cessations. The latest: Kunwar Krishanpal Singh was appointed as Whole-Time Director on 30 Jul 2019.
4 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Daffodills Pharmaceuticals Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Daffodills Pharmaceuticals Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Daffodills Pharmaceuticals Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Daffodills Pharmaceuticals Limited
Daffodills Pharmaceuticals has 3 GST registrations: 3 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAACD5022G1Z1 | Uttar Pradesh | Active | 01 Jul 2017 |
| 19AAACD5022G1Z0 | West Bengal | Active | 27 Oct 2018 |
| 36AAACD5022G1Z4 | Telangana | Active | 27 Oct 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Daffodills Pharmaceuticals Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Daffodills Pharmaceuticals Limited
Daffodills Pharmaceuticals is an active public limited company based in Meerut, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 May 1985 (41+ years old) and is registered under CIN U24233UP1985PLC007205.
Daffodills Pharmaceuticals reported revenue of ₹30.18 Cr for FY 2023 (up 32% YoY).
Daffodills Pharmaceuticals has 5 current directors:
- Prabhat Kumar Rai - Whole-Time Director
- Kunwar Krishanpal Singh - Whole-Time Director
- Pranav Chaudhary - Director
- Prateek Chaudhary - Director
- Prashant Chaudhry - Director
Daffodills Pharmaceuticals reported a net profit of ₹52.19 Lakh (net margin 1.7%) and EBITDA of ₹80.28 Lakh (EBITDA margin 2.7%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Daffodills Pharmaceuticals is -8% over three years and -1% over five years. In the latest year (FY 2023) revenue rose 32%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Daffodills Pharmaceuticals is 09AAACD5022G1Z1, registered in Uttar Pradesh. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 19AAACD5022G1Z0 (West Bengal), 36AAACD5022G1Z4 (Telangana).
The CIN (Corporate Identification Number) of Daffodills Pharmaceuticals is U24233UP1985PLC007205. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Daffodills Pharmaceuticals has 20 court cases on record: 15 filed by the company and 5 filed against it. 6 are pending. Most are in the high courts.
Daffodills Pharmaceuticals was incorporated on 28 May 1985, making it 41+ years old. It is registered with the Registrar of Companies, Kanpur.
Kunwar Krishanpal Singh was appointed as Whole-Time Director on 30 Jul 2019. Prabhat Kumar Rai was appointed as Whole-Time Director on 30 Jul 2019. Amit Dhaka ceased to be Director on 01 Sep 2018. Daffodills Pharmaceuticals has 8 board changes on record in total.